At the news
? NEUTRALIMPACT 2/10 144 filed Jun 30, 2026 at 16:00 ET
Director Jack Kaye filed a Form 144 to sell 21,167 ordinary shares (~$983K) as part of a pre-existing 10b5-1 plan adopted in June 2025. The sale is routine and represents a small fraction of the company's $3.0B market cap, with no material signaling value.
- Director Jack Kaye filed Form 144 to sell 21,167 ordinary shares.
- Estimated market value of proposed sale: $983,032.57.
- Sale is pursuant to a 10b5-1 trading plan adopted June 16, 2025.
- Prior sales by same insider in June 2026: 2,645 shares (06/03), 1,993 shares (06/11), 5,295 shares (06/17).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access